EPB41L4A-AS1
gene geneOn this page
Also known as EAS1TIGA1
Summary
EPB41L4A-AS1 (EPB41L4A antisense RNA 1, HGNC:30749) is a long non-coding RNA gene on chromosome 5q22.1.
Predicted to be involved in RNA processing. Predicted to be located in nucleolus.
Source: NCBI Gene 114915 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30749 |
| Approved symbol | EPB41L4A-AS1 |
| Name | EPB41L4A antisense RNA 1 |
| Location | 5q22.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | EAS1, TIGA1 |
| Ensembl gene | ENSG00000224032 |
| Ensembl biotype | lncRNA |
| Entrez | 114915 |
| RNAcentral | URS000075CCBD — lncRNA, 1194 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 12 lncRNA
ENST00000413221, ENST00000427306, ENST00000442823, ENST00000508590, ENST00000663232, ENST00000688370, ENST00000690733, ENST00000702181, ENST00000702686, ENST00000810489, ENST00000810490, ENST00000810491
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000413221 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002086360 | 112162151 | 112164257 |
| ENSE00003864704 | 112160872 | 112161295 |
| ENSE00003878953 | 112161686 | 112161775 |
Expression profiles
Bgee: expression breadth ubiquitous, 235 present calls, max score 98.53.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 61.1012 / max 533.8358, expressed in 1819 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 57987 | 58.9826 | 1819 |
| 57988 | 1.9888 | 999 |
| 57989 | 0.1297 | 44 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left ovary | UBERON:0002119 | 98.53 | gold quality |
| body of pancreas | UBERON:0001150 | 98.25 | gold quality |
| calcaneal tendon | UBERON:0003701 | 98.06 | gold quality |
| cortical plate | UBERON:0005343 | 97.83 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 97.80 | gold quality |
| right ovary | UBERON:0002118 | 97.60 | gold quality |
| mucosa of stomach | UBERON:0001199 | 97.41 | gold quality |
| ganglionic eminence | UBERON:0004023 | 97.35 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 97.25 | gold quality |
| cerebellar cortex | UBERON:0002129 | 97.23 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 97.07 | gold quality |
| skin of leg | UBERON:0001511 | 96.63 | gold quality |
| skin of abdomen | UBERON:0001416 | 96.60 | gold quality |
| endocervix | UBERON:0000458 | 96.39 | gold quality |
| cerebellum | UBERON:0002037 | 96.33 | gold quality |
| tendon | UBERON:0000043 | 96.26 | gold quality |
| body of uterus | UBERON:0009853 | 96.06 | gold quality |
| body of stomach | UBERON:0001161 | 96.01 | gold quality |
| tibial artery | UBERON:0007610 | 95.94 | gold quality |
| popliteal artery | UBERON:0002250 | 95.93 | gold quality |
| ectocervix | UBERON:0012249 | 95.85 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 95.78 | gold quality |
| tibial nerve | UBERON:0001323 | 95.40 | gold quality |
| ventricular zone | UBERON:0003053 | 95.20 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 95.14 | gold quality |
| minor salivary gland | UBERON:0001830 | 95.11 | gold quality |
| left uterine tube | UBERON:0001303 | 95.00 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 94.98 | gold quality |
| right uterine tube | UBERON:0001302 | 94.89 | gold quality |
| right frontal lobe | UBERON:0002810 | 94.87 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-10662 | yes | 1378.35 |
| E-ANND-3 | yes | 8.13 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 8)
- vascular calcification-associated factor (VCAF) is present in human calcified arteries but not noncalcified arteries (PMID:15994437)
- EPB41L4A-AS1 functions as a repressor of the Warburg effect by mediating nucleolar translocation of HDAC2. (PMID:30796006)
- miR-146a interacting with lncRNA EPB41L4A-AS1 and lncRNA SNHG7 inhibits proliferation of bone marrow-derived mesenchymal stem cells. (PMID:31612476)
- Long noncoding RNA EPB41L4A-AS1 functions as an oncogene by regulating the Rho/ROCK pathway in colorectal cancer. (PMID:32557646)
- LncRNA EPB41L4A-AS1 Regulates Cell Proliferation, Apoptosis and Metastasis in Breast Cancer. (PMID:35181612)
- IncRNA EPB41L4A-AS1 Mitigates the Proliferation of Non-Small-Cell Lung Cancer Cells through the miR-105-5p/GIMAP6 Axis. (PMID:36734855)
- Elevated exosome-transferrable lncRNA EPB41L4A-AS1 in CD56[bright] NK cells is responsible for the impaired NK function in neuroblastoma patients by suppressing cell glycolysis. (PMID:37024023)
- Downregulation of lncRNA EPB41L4A-AS1 promotes gastric cancer cell proliferation, migration and invasion. (PMID:38627627)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.